Beruflich Dokumente
Kultur Dokumente
Pharma 2005
An Industrial Revolution in R&D
Market 2005
Commercialisation
Elliot lives in a different world: 2015 His health agent is Dr. Thomas - a virtual person He knows Elliot and his behaviour He searches the globe looking for advances to improve Elliot s health Elliot receives the highest quality care at the lowest cost It is truly Individualised
Jeff Tolbert Illustration
Elliot lives in a different world: 2015 His health agent is Dr. Thomas - a virtual person He knows Elliot and his behaviour He searches the globe looking for advances to improve Elliot s health Elliot receives the highest quality care at the lowest cost It is truly Individualised
10
e-Environment
e-Environment
Technology
Science
11
The e-Environment is the fabric that binds and accelerates the convergence of forces
e-Commerce*:
e-Environment:
!
Deploying new technologies in the value chain Connecting businesses-tobusinesses and businesses-to-customers Leveraging customer insights
! !
Today
Tomorrow
12
GI Generation (b 1900-1930)
Generation X (b 1965-1985)
Source: Adapted from The Future of Complementary and Alternative Approaches in US Health Care Institute for Alternative Futures, July 1998
13
Users in Millions
19 95
19 96
19 97
19 98
19 99
20 00
Year
Source: Dataquest, 1999
20 01
14
Disease Info. Diet & Nutrition Pharmaceuticals Online Health Newsletters Women's Health Fitness Children's Health Illness Support Groups 0 10 20 30 40 50 60
15
16
Regenerative Implants
17
2000
Genotypes identified Genomes & transcriptomes identified
2005
2010
Existing drug Populations tested therapy for the disease Individualised to genotypes patient s genotype* Genetic test available Patients with predisposition to the disease tested
* Patient s therapy modified depending on genotype to affect : response to adverse effects metabolism, affecting required dose
18
19
Consumer Empowerment
Information Management
Science
Enhanced Market Opportunity: A Focus on the Individual will Lead to Raised Health Expectations
20
Wellness
Preventing Disease Managing Health
Treating Disease
Managing Disease
Biological Continuum
SM
21
Treating Disease
Managing Disease
Osteoporosis Arthritis
Illness
Acute
PharmaFramework SM
SM
22
Treating Disease
Managing Disease
Hypertension
Illness
Acute
Chronic
PharmaFramework SM
Opportunities in Individualised Health Management: Realised through Partnerships, Networks, and Alliances
Virtual Rx Company
23
Biotech
Algorithm Designer
CROs
Pharmacy
?
Health Clubs Group Practices
Hospital
24
25
Solution Sets: Products & Services Segmenting in New Ways Establishing Corporate Identity & Branding
Integrating Individualised Market Intelligence into Seamless Commercialisation Processes Leveraging the e-Environment Relationship Building, Planning Adaptively Partnering & Networking
Foundation for Individualised Health Management: Segmenting Changing Customer Groups in New Ways
Payers Patients & Consumers Payers Individuals Physicians & Providers Customer Groups Physicians & Providers Customer Groups Health Agents
26
Today
Tomorrow
Segmenting in New Ways Surpass current narrow focus Enable effective targeting Critical to competitive position
Foundation for Individualised Health Management: Establishing Corporate Identity and Branding
Previous focus on product branding insufficient Need to augment with corporate identity
27
Opportunity to learn from other industries Branding and outcomes must be supportive!
Foundation for Individualised Health Management: Individualised Market Intelligence Critical to Decision Making
Individualised Market Intelligence: data on the needs, values, expectations, behaviours and outcomes of individual customers
28
Innovation
Customer Groups
29
Interpret
Analyse
Model
Foundation for Individualised Health Management: Evolving Opportunities to Leverage the e-Environment
e-Pharmacy Interactions e-Detailing & e-Sampling
R X
30
On-demand CME
Reimbursement Data